Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E226.57 EPS (ttm)0.42 Insider Own0.20% Shs Outstand142.61M Perf Week2.66%
Market Cap13.67B Forward P/E10.36 EPS next Y9.25 Insider Trans-13.91% Shs Float136.61M Perf Month-0.71%
Income62.10M PEG28.37 EPS next Q2.01 Inst Own80.40% Short Float4.19% Perf Quarter-23.95%
Sales4.30B P/S3.18 EPS this Y-95.80% Inst Trans5.51% Short Ratio2.17 Perf Half Y-36.14%
Book/sh70.17 P/B1.37 EPS next Y12.18% ROA- Target Price121.75 Perf Year-50.13%
Cash/sh- P/C- EPS next 5Y7.99% ROE- 52W Range84.72 - 197.59 Perf YTD-33.59%
Dividend0.58 P/FCF- EPS past 5Y-59.80% ROI0.80% 52W High-51.49% Beta0.26
Dividend %0.61% Quick Ratio0.70 Sales past 5Y0.10% Gross Margin40.40% 52W Low13.12% ATR3.32
Employees13242 Current Ratio1.60 Sales Q/Q31.80% Oper. Margin- RSI (14)42.33 Volatility2.17% 2.97%
OptionableYes Debt/Eq0.65 EPS Q/Q- Profit Margin- Rel Volume0.84 Prev Close96.61
ShortableYes LT Debt/Eq0.59 EarningsMay 12 BMO Payout- Avg Volume2.64M Price95.84
Recom2.70 SMA202.51% SMA50-13.98% SMA200-33.03% Volume2,200,972 Change-0.80%
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Apr-10-15Downgrade Argus Buy → Hold
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
May-31-16 02:01AM  Perrigo Announces FDA Approval And Launch Of The Store Brand Equivalent To Flonase® PR Newswire
May-27-16 11:53AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Perrigo Company plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 -- PRGO Marketwired
May-25-16 10:55AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Perrigo Company plc - PRGO PR Newswire
May-24-16 10:10PM  Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Perrigo Company plc to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit PRGO GlobeNewswire
06:27PM  Robbins Arroyo LLP: Perrigo Company plc (PRGO) Misled Shareholders According to a Recently Filed Class Action Business Wire
03:31PM  ETFs with exposure to Perrigo Co. Plc : May 24, 2016
03:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Perrigo Company plc (PRGO) and Lead Plaintiff Deadline July18, 2016 Accesswire
01:10PM  Lawsuit filed against former Mylan acquisition target Perrigo at bizjournals.com
10:50AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 - PRGO GlobeNewswire
10:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Perrigo Company plc (PRGO) and Lead Plaintiff Deadline July 18, 2016 PR Newswire
May-23-16 01:20PM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
10:56AM  Valeant: Turning Over a New Guidance Leaf? at The Wall Street Journal
May-20-16 10:07PM  PERRIGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO GlobeNewswire
10:46AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 PRGO GlobeNewswire
May-19-16 05:00PM  Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against Perrigo Company, plc PR Newswire
May-18-16 05:51PM  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Joseph C. Papa And Perrigo Company plc PR Newswire
09:43AM  Perrigo Company to Present at the UBS Global Healthcare Conference PR Newswire
May-17-16 04:45PM  Perrigo shares sway on quarterly results at CNBC
04:45PM  Perrigo shares sway on quarterly results at CNBC
12:24PM  Investors Comforted as Perrigo Sticks to Forecast at TheStreet
May-16-16 10:16PM  [$$] Perrigo Updates First-Quarter Loss Figure to Reflect Lower Tax Benefit at The Wall Street Journal
06:27PM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:28PM  Correcting and Replacing GAAP Net Loss on Consolidated Statement of Operations for First Quarter 2016 PR Newswire
May-13-16 09:00PM  Papa's New Bag; Sears About to Become a Swan: Best of Kass at TheStreet
04:10PM  Perrigo (PRGO) Stock Price Target Reduced at Leerink at TheStreet
12:20PM  Is Valeant Haunted By Past And Future Ghosts? Gadfly Wonders Benzinga
12:00PM  Mylan Tacks On Another Generics Company on the Cheap at TheStreet
08:00AM  Valeant Haunted By Ghosts of Past, Future at Bloomberg
01:18AM  [$$] Perrigo Avoids Valeant-Like Drama at The Wall Street Journal
May-12-16 04:48PM  Valeant Whipsawed by Criticism Over Drug Prices and New Leadership at TheStreet
03:21PM  New Regime at Perrigo Provides Reason to Invest at TheStreet
01:22PM  [$$] Perrigo Avoids Valeant-Like Drama at The Wall Street Journal
01:03PM  Edited Transcript of PRGO earnings conference call or presentation 12-May-16 12:00pm GMT Thomson Reuters StreetEvents
12:12PM  Valeant Slumps as New CEO Faulted by Successor at Perrigo at Bloomberg
09:46AM  Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact Zacks
08:01AM  Trending Now: PRGO Yahoo Finance - Qwiki
07:39AM  Perrigo (PRGO) Beats Q1 Earnings and Revenue Estimates Zacks
07:32AM  Perrigo Gives CFO Brown Expanded Role at The Wall Street Journal
07:11AM  [$$] Perrigo Loss Deepens at The Wall Street Journal
07:07AM  Q1 2016 (Calendar) Perrigo Company PLC Earnings Release - Before Market Open CCBN
06:24AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:09AM  Perrigo reports 1Q loss AP
05:57AM  Perrigo Company plc Reports First Quarter 2016 Financial Results PR Newswire
May-11-16 01:20PM  What to Look For When Perrigo (PRGO) Reports Q1 Results at TheStreet
10:41AM  Perrigo Company plc To Release First Quarter Calendar Year 2016 Results On May 12, 2016 PR Newswire
May-10-16 07:02PM  Cramer: The World Is Gunning for Valeant at TheStreet
May-09-16 01:22PM  Perrigo Severely Overvalued As CEO Departs For Valeant at Forbes
01:08PM  Horizon Pharma: Five Reasons It's Flying at Barrons.com
11:44AM  Perrigo Company PLC Had an Abominable April, and May Isn't Looking Any Merrier at Motley Fool
May-07-16 12:01AM  [$$] Questioning Perrigo's Growth at Barrons.com
May-06-16 04:09PM  Generic Drug Stocks Crash, As Endo Warns Of Price Erosion at Investor's Business Daily
01:39PM  After Endo's Plunge, These Stocks Could Be Next at Barrons.com
May-04-16 04:50PM  Perrigo Bears Turn Aggressive at TheStreet
May-03-16 04:17PM  Valeant Pharmaceuticals Intl. Inc. Jumped 27% in April, But It's Not Out of the Woods at Motley Fool
01:55PM  Valeant Shares Spike as New CEO Joseph Papa Takes Office at TheStreet
01:18PM  Valeant (VRX) Stock Soars as Papa Assumes CEO Role at TheStreet
08:53AM  Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex® 1200mg DM Extended-Release Tablets PR Newswire
02:48AM  Mylan Braces for Continued Generic Drug Price Declines at Bloomberg
May-02-16 04:04PM  The 52-Week Low Club for Monday at 24/7 Wall St.
09:30AM  The Zacks Analyst Blog Highlights: Perrigo Company, Xerox, Apple, DuPont and Boeing Zacks
09:02AM  Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin® Pump Topical Gel PR Newswire
May-01-16 02:00PM  It's Scary Down There: Buying at the Lows at TheStreet
Apr-30-16 05:00PM  Short Sellers Target Perrigo After CEO Exit as Goldman Says Sell at Bloomberg
Apr-29-16 10:51AM  Look to the Companies; Chinese Demand Is for Real: Jim Cramer's Best Blogs at TheStreet
Apr-28-16 04:48PM  The 52-Week Low Club for Thursday at 24/7 Wall St.
12:46PM  Heres how much money it took for Perrigos ex-CEO to leave for Valeant at MarketWatch
06:34AM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
02:00AM  Perrigo Expands the Responsibilities of Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, to Lead the Branded Consumer Healthcare Segment PR Newswire
Apr-27-16 10:14PM  Valeants Michael Pearson Admits Aggressive Drug-Price Increases Were a Mistake at The Wall Street Journal
08:55PM  [$$] Valeant's Pearson Admits Aggressive Drug-Price Increases Were a Mistake at The Wall Street Journal
08:27PM  Valeant Discloses Pay for New CEO at The Wall Street Journal
07:48PM  Valeant to pay new CEO Papa base salary of $1.5 million Reuters
06:21PM  Valeant to pay new CEO Papa base salary of $1.5 mln Reuters
05:02PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:54PM  Will Joseph Papa Be Able to Change Valeant? Bloomberg
04:04PM  The 52-Week Low Club for Wednesday at 24/7 Wall St.
Apr-26-16 04:23PM  3D Systems Downgraded, GE PT Cut, Disney Gets PT Hike at Investor's Business Daily
04:04PM  The 52-Week Low Club for Tuesday at 24/7 Wall St.
02:34PM  Is There Any Hope for Perrigo Stock? at TheStreet
01:36PM  Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles Zacks
10:10AM  Stock Market News for April 26, 2016 Zacks
09:43AM  A.M. Funds Roundup: Time To Simplify Your Fund Portfolio? at Barrons.com
09:26AM  Perrigo (PRGO) Stock Falls as Jefferies Downgrades on Guidance Cut at TheStreet
08:55AM  Top Analyst Upgrades and Downgrades: Broadcom, Caterpillar, Sirius XM, Newmont, Palo Alto, Perrigo, Sarepta, Xerox and More at 24/7 Wall St.
08:45AM  Forex Traders Look Past Fed to Bank of Japan at The Wall Street Journal
08:24AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
07:24AM  Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One at TheStreet
07:00AM  The Trader Daily: Volatility Cuts Both Ways at TheStreet
05:00AM  New Valeant CEO Papa Trades Challenge at Perrigo for Fresh One at Bloomberg
12:49AM  [$$] Perrigos Pain Isnt Just About Valeant at The Wall Street Journal
12:48AM  [$$] CEO Exits Show That Room at the Top Can Be Lonely at The Wall Street Journal
12:48AM  [$$] As Its CEO Leaves for Valeant, Perrigo Continues to Struggle at The Wall Street Journal
12:47AM  [$$] Valeant Names Joseph Papa as New CEO at The Wall Street Journal
12:15AM  PRESS DIGEST- New York Times business news - April 26 Reuters
Apr-25-16 06:47PM  Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One at TheStreet -18.09%
06:27PM  Valeant names Papa CEO after he resigns from Perrigo Reuters
05:40PM  Can Papa save Valeant CNBC
05:37PM  Why Perrigo, U.S. Steel, and GoPro Slumped Today at Motley Fool
05:35PM  Embattled drugmaker Valeant taps Papa as new CEO at USA TODAY
05:23PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM
Farrington ThomasEVP and CIONov 30Sale151.0335052,8611,194Dec 02 09:29 AM
Gottfried RanDirectorNov 19Option Exercise100.842,726274,89015,454Nov 23 04:17 PM
Gottfried RanDirectorNov 19Sale154.342,726420,72212,728Nov 23 04:17 PM
MORRIS HERMAN JRDirectorNov 18Sale155.6455085,602850Nov 20 07:35 PM
KUNKLE GARY K JRDirectorNov 13Option Exercise146.901,929283,37026,133Nov 17 04:57 PM
JANDERNOA MICHAEL JDirectorNov 13Option Exercise146.901,929283,3702,797Nov 17 04:57 PM
BRLAS LAURIEDirectorNov 13Option Exercise146.901,929283,37010,903Nov 17 04:58 PM
Hoffing Ellen RandiDirectorNov 13Option Exercise146.901,929283,3709,530Nov 17 04:56 PM
FOUSE JACQUALYN ADirectorNov 13Option Exercise146.901,929283,3704,362Nov 17 04:56 PM
COHEN GARY MDirectorNov 13Option Exercise146.901,929283,37013,797Nov 17 04:56 PM
MORRIS HERMAN JRDirectorNov 13Option Exercise146.901,929283,3705,057Nov 17 04:57 PM
O'Connor DonalDirectorNov 13Option Exercise146.901,929283,3702,173Nov 17 04:57 PM
GIBBONS DAVID TDirectorNov 04Option Exercise162.291,929313,05715,104Nov 05 04:16 PM
Gottfried RanDirectorNov 04Option Exercise162.291,929313,05713,654Nov 06 05:22 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 25Sale181.371,737315,0400Aug 27 03:32 PM
KINGMA TODD WExecutive VP, General CounselAug 25Sale181.371,715311,05010,320Aug 27 03:32 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Option Exercise114.604,468512,0314,131Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Sale177.684,468793,8701,737Aug 25 06:21 PM
Jamison Scott FExecutive Vice President PBMAug 21Option Exercise186.89552103,1635,379Aug 25 06:21 PM
Stewart Michael RobertSr. VP Global Human ResourcesAug 21Option Exercise186.89552103,1631,398Aug 25 06:21 PM
Shah JatinSr VP & Chief Scientific OfficAug 21Option Exercise186.89552103,1634,619Aug 25 06:22 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 21Option Exercise186.89967180,7237,646Aug 25 06:20 PM
Kochan SharonEVP, GM InternationalAug 21Option Exercise186.89967180,7237,731Aug 25 06:20 PM
PAPA JOSEPH CPresident and CEOAug 21Option Exercise186.897,3651,376,445123,234Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 21Option Exercise186.891,022191,0022,223Aug 25 06:21 PM
Farrington ThomasSenior VP and CIOAug 21Option Exercise186.89552103,1631,719Aug 25 06:19 PM
Boothe DouglasEVP & GM Perrigo PharmaAug 21Option Exercise186.8939573,822951Aug 25 06:19 PM
KINGMA TODD WExecutive VP, General CounselAug 21Option Exercise186.891,409263,32812,686Aug 25 06:19 PM
Yu LouisExecutive VP Global QualityAug 21Option Exercise186.89552103,1636,327Aug 25 06:20 PM
Brown Judy LExecutive VP & CFOAug 21Option Exercise186.892,578481,80213,621Aug 25 06:20 PM